Development of a novel tool for individual treatment trials in mucopolysaccharidosis

Documenti analoghi

• Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapy
  di: Christoph Kampmann, et al.
  Pubblicazione: (2024)
• Induced Pluripotent Stem Cells for the Treatment of Lysosomal Storage Disorders
  di: Maryann Lorino, et al.
  Pubblicazione: (2025)
• Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase‐ IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II
  di: Joseph Muenzer, et al.
  Pubblicazione: (2024)
• From Molecule to Meaning: Neuronopathic Biomarkers and Clinical Relevance in GM1
  di: Krista Casazza, et al.
  Pubblicazione: (2026)
• Long‐term cardiovascular outcomes and mortality with enzyme replacement therapy in patients with mucopolysaccharidosis type II
  di: Ji Hee Kwak, et al.
  Pubblicazione: (2024)